Covid-19 Outbreak in Italy: An Opportunity to Evaluate Extended Interval Dosing of Ocrelizumab in MS Patients (P2-6.010)
Alvino Bisecco, Federica Matrone, Marco Capobianco, Giovanna De Luca, Massimo Filippi, Franco Granella, Giacomo Lus, Girolama Alessandra Marfia, Massimiliano Mirabella, Francesco Patti, María Trojano, Agnese Mascolo, Massimiliano Copetti, Gioacchino Tedeschi, Antonio Gallo (2024). Covid-19 Outbreak in Italy: An Opportunity to Evaluate Extended Interval Dosing of Ocrelizumab in MS Patients (P2-6.010). , 102(7_supplement_1), DOI: https://doi.org/10.1212/wnl.0000000000206347.
